Form 4: Allovir CFO Vikas Sinha Sells Shares to Cover Tax Obligations

Vikas Sinha, CFO of Allovir, Inc., sold shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Summary

• Vikas Sinha, the President and CFO of Allovir, Inc., reported the sale of Allovir common stock on July 19, 2024, and July 22, 2024.
• These sales were executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• On July 19, 2024, 1,542 shares were sold at a weighted average price of $0.7501.
• On July 22, 2024, 1,858 shares were sold at a weighted average price of $0.7392.
• Following these transactions, Sinha directly owns 1,161,994 shares of Allovir common stock.
• Sinha may also be deemed to have shared voting and investment power over 16,674,766 shares held by ElevateBio LLC, where he serves as a director and CFO, but he disclaims beneficial ownership except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: This is a neutral event. It reflects routine transactions related to executive compensation and tax obligations.

Industry Context

This is a routine filing related to insider transactions and is common for executives who receive stock-based compensation.

Stakeholder Impact

• The impact on shareholders is likely minimal, as the transactions are related to tax obligations and do not necessarily reflect a change in the executive's long-term outlook on the company.

Key Dates